Literature DB >> 23915846

Chemotherapy for advanced or recurrent cervical cancer.

Toshiharu Kamura1, Kimio Ushijima.   

Abstract

The primary treatment options for cervical cancer are surgery and radiation for more than a century. However, over the last 40 years chemotherapy has been building up its reputation in the management of cervical cancer in various forms such as chemoradiation, neoadjuvant chemotherapy, and palliative chemotherapy for advanced or recurrent disease. Among these, in this review, chemotherapy for advanced or recurrent cervical cancer will be discussed.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  advanced or recurrent cervical cancer; chemotherapy; palliative therapy

Mesh：

Substances：

Year:  2013        PMID： 23915846     DOI： 10.1016/j.tjog.2013.04.003

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN： 1028-4559            Impact factor:   1.705


  5 in total

1.  Cervical cancer is addicted to SIRT1 disarming the AIM2 antiviral defense.

Authors:  Daeho So; Hyun-Woo Shin; Jiyoung Kim; Mingyu Lee; Jongyun Myeong; Yang-Sook Chun; Jong-Wan Park
Journal:  Oncogene       Date:  2018-05-29       Impact factor: 9.867

Review 2.  Human papillomavirus infection, cervical cancer and the less explored role of trace elements.

Authors:  Anne Boyina Sravani; Vivek Ghate; Shaila Lewis
Journal:  Biol Trace Elem Res       Date:  2022-04-25       Impact factor: 3.738

Review 3.  Image-Guided Brachytherapy for Salvage Reirradiation: A Systematic Review.

Authors:  Sophie Bockel; Sophie Espenel; Roger Sun; Isabelle Dumas; Sébastien Gouy; Philippe Morice; Cyrus Chargari
Journal:  Cancers (Basel)       Date:  2021-03-11       Impact factor: 6.639

4.  Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer.

Authors:  Md Selim Reza; Md Harun-Or-Roshid; Md Ariful Islam; Md Alim Hossen; Md Tofazzal Hossain; Shengzhong Feng; Wenhui Xi; Md Nurul Haque Mollah; Yanjie Wei
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

5.  Metadata analysis to explore hub of the hub-genes highlighting their functions, pathways and regulators for cervical cancer diagnosis and therapies.

Authors:  Md Selim Reza; Md Alim Hossen; Md Harun-Or-Roshid; Mst Ayesha Siddika; Md Hadiul Kabir; Md Nurul Haque Mollah
Journal:  Discov Oncol       Date:  2022-08-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.